← Leaderboards
Ian Henderson
Dynport Vaccine Company, Llc
$11,140,403
Attributed
$11,140,403
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–07$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
Funding mix
By agency
NIH$11,140,403 · 1
By mechanism
U01$11,140,403 · 1
Top collaborators
No co-investigators on record.
Most similar at Dynport Vaccine Company, Llc
Same institution · by research overlap
- John T. Ross$5,388,306
- Donald L Fine$9,996,228
Others in their field
Top investigators on “Enzyme Linked Immunosorbent Assay”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,730,646
- Philip Louis Felgner · Gene Therapy Systems, Inc.$41,441,562
- Marianne Ward · Duke University$21,475,073
- Andrew B Norman · University Of Cincinnati$21,321,632
- Eric S. Orwoll · Oregon Health And Science University$20,906,524
- Andrew E. Levin · Immunetics, Inc.$20,730,152
Research focus
Enzyme Linked Immunosorbent AssayLaboratory MouseBioterrorism /Chemical WarfareDrug Screening /EvaluationClinical ResearchClostridium BotulinumCooperative StudyNeurotoxinsNeutralizing AntibodyNonhuman Therapy EvaluationPlasmidsSerotypingVaccine DevelopmentWestern BlottingsBacterial VaccinesBiotechnologyBotulinum ToxinsAscomycetesVector VaccineVaccine Evaluation
Grant awards (5)
Fast-Track Production of a Heptavalent Botulinum Vaccine$288,859
U01 · FY2007 · AI · contact PI
Fast-Track Production of a Heptavalent Botulinum Vaccine$2,813,296
U01 · FY2006 · AI · contact PI
Fast-Track Production of a Heptavalent Botulinum Vaccine$2,997,064
U01 · FY2005 · AI
Fast-Track Production of a Heptavalent Botulinum Vaccine$3,134,091
U01 · FY2004 · AI
Fast-Track Production of a Heptavalent Botulinum Vaccine$1,907,093
U01 · FY2003 · AI